Quantitative proteomics approach reveals novel biomarkers and pathological mechanism of keloid.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 4, p. 1, doi. 10.1002/prca.202100127
- By:
- Publication type:
- Article
Works matching IS 18628346 AND DT 2022 AND VI 16 AND IP 4
Results: 8
1
2
Placental and plasma early predictive biomarkers for gestational diabetes mellitus.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 4, p. 1, doi. 10.1002/prca.202200001
- By:
- Publication type:
- Article
3
Are mass spectrometry imaging‐based diagnostics becoming reality?
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 4, p. 1, doi. 10.1002/prca.202200017
- Publication type:
- Article
4
Robust subtyping of non‐small cell lung cancer whole sections through MALDI mass spectrometry imaging.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 4, p. 1, doi. 10.1002/prca.202100068
- By:
- Publication type:
- Article
5
Prognostic value of protein biomarkers in liver transplantation: A systematic review.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 4, p. 1, doi. 10.1002/prca.202100038
- By:
- Publication type:
- Article
6
Masthead: Proteomics 4'22.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 4, p. 1, doi. 10.1002/prca.202270043
- Publication type:
- Article
7
Editorial Board: Proteomics 4'22.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 4, p. 1, doi. 10.1002/prca.202270042
- Publication type:
- Article
8
Front Cover.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 4, p. 1, doi. 10.1002/prca.202270041
- Publication type:
- Article